Onconetix, Inc. Earnings Per Share Diluted

Quick Answer

Onconetix, Inc. reported Earnings Per Share Diluted of $16.56 (loss) per share for the year ending 2025.

  • Onconetix, Inc. showed an increase of +99.1% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Onconetix, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), Onconetix, Inc.'s Earnings Per Share Diluted has declined by 1,214.3%.
  • Historical annual values: Fiscal year 2025: $16.56 (loss) per share | Fiscal year 2024: $1,823.39 (loss) per share | Fiscal year 2023: $87.45 (loss) per share | Fiscal year 2022: $1.10 (loss) per share | Fiscal year 2021: $1.26 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: